Skip to content

Annual General Meetings Archive

Here you will find information on our Annual General Meetings from 2012 to 2023.

Extraordinary General Meeting 2023

The Extraordinary General Meeting of Fresenius Medical Care AG & Co. KGaA took place on Friday, 14 July 2023 at 10:00 hours (CEST) at the Congress Center, Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany.

The documents and the further information to be made available pursuant to section 278 (3) AktG in connection with section 124a AktG as well as all other information pertaining to the General Meeting are available below.

Press release

"For many years now, I have been contributing my expertise and energy to the Supervisory Board of Fresenius Medical Care. During this time, profound changes have taken place."

Dr. Dieter Schenk
Chairman of the Supervisory Board


Letter

The opening of the Extraordinary General Meeting by the Chair of the meeting, Dr. Dorothea Wenzel, and the report of CEO and Chair of the Management Board, Helen Giza, were transmitted publicly. 
 

Replay

Frequently asked questions regarding the Extraordinary General Meeting (EGM) of Fresenius Medical Care AG & Co. KGaA

EGM Q&A

Peter Kartscher has been the responsible German Public Auditor since 2020.

Annual General Meeting 2023

The Annual General Meeting of Fresenius Medical Care AG & Co. KGaA took place on Tuesday, 16 May 2023.

The documents and the further information to be made available pursuant to section 278 (3) AktG in connection with section 124a AktG as well as all other information pertaining to the General Meeting are available below.

"In the run-up to our virtual Annual General Meeting on May 16, 2023, I would like to provide you with a summary of the developments that have been a focus in our conversations with the Management Board and of the important strategic steps that lie ahead of us."

Dr. Dieter Schenk
Chairman of the Supervisory Board

Letter

The opening of the Annual General Meeting by the Chairman of the Supervisory Board, Dr. Dieter Schenk, and the report of CEO and Chair of the Management Board, Helen Giza, was transmitted publicly. 

The manuscript of the speech of CEO and Chair of the Management Board, Helen Giza, both in German and English, is now available below. As usual with pre-release publications, the spoken word shall prevail.

Speech of Helen Giza, CEO and Chair of the Management Board

Replay

Peter Kartscher has been the responsible German Public Auditor since 2020.

Sustainability disclosures

We are committed to providing transparent and relevant sustainability information to our stakeholders. The tables below give a comprehensive overview of our sustainability performance:

Annual General Meeting 2022

AGM 2021

The Annual General Meeting of Fresenius Medical Care AG & Co. KGaA took place on Thursday, 12 May 2022 as a virtual General Meeting without the physical presence of shareholders or their proxies.

The documents and the further information to be made available pursuant to section 278 (3) AktG in connection with section 124a AktG as well as all other information pertaining to the General Meeting are available below.

"In the run-up to our virtual Annual General Meeting I would like to give you a summary on the developments which have impacted Fresenius Medical Care’s business in the past year. These trends are also likely to remain with us in the coming months."

Dr. Dieter Schenk
Chairman of the Supervisory Board

Letter

Fresenius Medical Care Shareholder Portal

The General Meeting was broadcasted in full in audio and video on 12 May 2022 from 10:00 hours CEST for registered shareholders via the Shareholder Portal.

The following functions were available to shareholders in the Shareholder Portal:

1. Issue powers of attorney and instructions to the proxies named by the Company
2. Authorization of Third Parties
3. Voting by postal vote
4. Submitting questions to the Company 
(by 10 May 2022, 24:00 hours CEST, at the latest)
5. Objections (during the General Meeting)
6. Information on the provision of confirmation on whether and how votes were counted pursuant to section 129 (5) AktG (can be found in the Shareholder Portal in a timely manner after the General Meeting)
7. Submission of statements in video form (by 8 May 2022, 24:00 hours CEST, at the latest) and view published statements (until the end of the General Meeting)

Video webcast

The opening of the Annual General Meeting by the Chairman of the Supervisory Board, Dr. Dieter Schenk, and the report of the Former CEO and Chairman of the Management Board, Rice Powell, were transmitted publicly. 

Speech

The manuscript of the speech of the Former CEO and Chairman of the Management Board, Rice Powell, both in German and English, was available in advance (published on May 5, 2022). As usual with pre-release publications, the spoken word shall prevail.

Report of the Former CEO and Chairman of the Management Board, Rice Powell

Replay

Sustainability disclosures

We are committed to providing transparent and relevant sustainability information to our stakeholders. The tables below give a comprehensive overview of our sustainability performance:

Below you will find the countermotion from a shareholder within the meaning of Section 126 of the German Stock Corporation Act (Aktiengesetz) on item 4 of the agenda of the virtual Annual General Meeting of Fresenius Medical Care AG & Co. KGaA on May 12, 2022 and the position of the Management.

Countermotion from a shareholder

Statement of the Management on the countermotion

Annual General Meeting 2021

The Annual General Meeting of Fresenius Medical Care AG & Co. KGaA took place on Thursday, May 20, 2021 as a virtual General meeting without the physical presence of shareholders or their proxies.

The documents and the further information to be made available pursuant to section 278 (3) AktG in connection with section 124a AktG as well as all other information pertaining to the General Meeting are available below.

Sustainability Disclosures

We are committed to providing transparent and relevant sustainability information to our stakeholders. The tables below give a comprehensive overview of our sustainability performance:

Below you will find the countermotion from a shareholder within the meaning of Section 126 of the German Stock Corporation Act (Aktiengesetz) on item 4 of the agenda of the virtual Annual General Meeting of Fresenius Medical Care AG & Co. KGaA on May 20, 2021 and the position of the Management.

Countermotion from a shareholder

Statement of the Management on the countermotion

Annual General Meeting 2015

The Annual General Meeting took place at the Congress Center Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany on May 19, 2015.

Out of the capital stock of EUR 311,490,141.00, 231,089,144 shares were represented, which accounted for 74.19% of the share capital.

Annual General Meeting 2014

The Annual General Meeting took place at the Congress Center Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany on May 15, 2014.

Out of the capital stock of EUR 309,137,900, 229,617,455 shares were represented, which accounted for 74.28% of the share capital.

Speech by Rice Powell

Presentation accompanying the speech by Rice Powell

Voting results

Agenda

Information for ADR-holders

Explanations on the rights of shareholders

Financial statements and management report 2013 (only in German)

Consolidated financial statements and consolidated management report 2013 (only in German)

Report sec. 289 p. 4, Sec. 315 p. 4 German Commercial Code

Report sec. 289 p. 5 German Commercial Code

Report of the Supervisory Board

Annual report 2013

Declaration on Corporate Governance

Report of Joint Committee of 12 March 2014

Profit and loss transfer agreement of 23 December 1997

Amendment agreement regarding the profit and loss transfer agreement of 23 December 1997

Wording of the profit and loss transfer agreement of 23 December 1997 following the amendment agreement of 12 March 2014 (for illustrative purposes)

Financial statements and management report of Fresenius Medical Care AG & Co. KGaA 2013 (only in German)

Financial statements and management report of Fresenius Medical Care AG & Co. KGaA 2012 (only in German)

Financial statements and management report of Fresenius Medical Care AG & Co. KGaA 2011 (only in German)

Financial statements of Fresenius Medical Care Beteiligungsgesellschaft mbH 2013 (only in German)

Financial statements of Fresenius Medical Care Beteiligungsgesellschaft mbH 2012 (only in German)

Financial statements of Fresenius Medical Care Beteiligungsgesellschaft mbH 2011 (only in German)

Joint report of the management board of the general partner of Fresenius Medical Care AG & Co. KGaA, Fresenius Medical Care Management AG, and the management board of Fresenius Medical Care Beteiligungsgesellschaft mbH

Supplemental information

Form 20-F 2013

Articles of Association

Annual General Meeting 2013

The ordinary General Meeting took place on May 16, 2013 at the Congress Center Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt/Main, Germany.

Out of the ordinary capital stock of EUR 302,921,871, 226,072,802 ordinary shares were represented, which accounted for 74.63% of the ordinary share capital.

138,947 preference shares, which is 3.50% of the preference capital were represented. The capital stock of preference shares is EUR 3,973,333.

All in all, 73.71% of the capital stock of EUR 306,895,204 was represented. This corresponds to 226,211,749 shares.

Separate meeting of preference shareholders 2013

The separate meeting of the preference shareholders took place on May 16, 2013 at the Congress Center Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt/Main, Germany.

Out of the preference capital stock of EUR 3,973,333.00, 3,210,711 preference shares were represented, which accounted for 80.81% of the preference share capital.

Annual General Meeting 2012

The Annual General Meeting took place on May 10, 2012 at the Congress Center Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany.

Out of the ordinary capital stock of EUR 300,265,231.00, 234,005,141 ordinary shares were represented, which accounted for 77.93% of the ordinary share capital.

77,617 preference shares, which is 1.96% of the preference capital were represented. The capital stock of preference shares is EUR 3,966,522.00.

All in all, 76.94% of the capital stock of EUR 304,231,753.00 was represented. This corresponds to 234,082,758 shares.

Contact us for further information
Related content

Fresenius Medical Care is committed to responsible management that is focused on achieving a sustainable increase in the value of the Company.

Read more about Fresenius Medical Care’s dividends in the past years including the dividend calendar for the fiscal year.